AbbVie Inc. (ABBV): Price and Financial Metrics

AbbVie Inc. (ABBV): $165.44

0.98 (-0.59%)

POWR Rating

Component Grades








Add ABBV to Watchlist
Sign Up

ABBV Price/Volume Stats

Current price $165.44 52-week high $182.89
Prev. close $166.42 52-week low $130.96
Day low $164.68 Volume 393,616
Day high $166.42 Avg. volume 5,505,336
50-day MA $169.54 Dividend yield 3.77%
200-day MA $158.38 Market Cap 292.15B

ABBV Stock Price Chart Interactive Chart >

AbbVie Inc. (ABBV) Company Bio

Abbvie develops and markets therapies that address a range of diseases. The Company's products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn's disease, hepatitis C, human immunodeficiency virus, endometriosis, thyroid disease, Parkinson's disease, complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone. The company was founded in 2012 and is based in North Chicago, Illinois.

ABBV Latest News Stream

Event/Time News Detail
Loading, please wait...

ABBV Latest Social Stream

Loading social stream, please wait...

View Full ABBV Social Stream

Latest ABBV News From Around the Web

Below are the latest news stories about ABBVIE INC that investors may wish to consider to help them evaluate ABBV as an investment opportunity.

The 3 Hottest Dividend Stocks to Watch in 2024

You know what I hate about the typical article about hottest dividend stocks to watch?

Josh Enomoto on InvestorPlace | January 1, 2024

Top 15 Value Stocks to Buy for 2024

In this article, we discuss top 15 value stocks to buy for 2024 picked by Joel Greenblatt. To skip the details about Mr. Greenblatt’s life, portfolio performance, and investment strategy, go directly to Top 5 Value Stocks to Buy for 2024. Investing offers an exciting and effective way of growing wealth over time. Value investing is […]

Yahoo | December 28, 2023

AbbVie (ABBV) Laps the Stock Market: Here's Why

AbbVie (ABBV) closed at $154.88 in the latest trading session, marking a +0.17% move from the prior day.

Yahoo | December 27, 2023

AstraZeneca (AZN) Set to Acquire Gracell for $1.2 Billion

AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion.

Yahoo | December 27, 2023

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

In pharma, a company can take a larger slice of the healthcare pie than peers, but it is still constrained by the size of the pie.

Yahoo | December 27, 2023

Read More 'ABBV' Stories Here

ABBV Price Returns

1-mo -0.58%
3-mo -4.99%
6-mo 21.75%
1-year 18.64%
3-year 60.60%
5-year 154.43%
YTD 8.78%
2023 -0.23%
2022 24.01%
2021 32.43%
2020 27.72%
2019 1.47%

ABBV Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ABBV Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!